4Wang H,Chen M,Ni Y,et al.Antimicrobial resistance analysis among nosocomial gram-negative bacilli from 10 teaching hospitals in China[J].Clin Lab Med,2005,28(12):1295-1303.
5Levin AS,Barone AA,Penco J,et al.Intravenous colistin as therapy for nosocomial infections caused by multi-drug resistance pseudomonas aeruginosa and acinetlbacter baumannii[J].Clin Infect Dis,1999,28(5):1008-1011.
6Clinical and Laboratory Standards Institute/NCCLS.Performance standards for antimicrobial susceptiblity testing;Fifteenth informational supplement.CLSI/NCCLS document MIO0-S15[J].Clinical and Laboratory Standards Institute,Wayne,Pennsylvania,2005,25(1):10-155.
7Appelbaum PC.The emergence of vancomycirr intermediate and vancomycin resistant staphylococcus aureus[J].Clin Microbiol Infect,2006,12(1):16-19.
8YANG T,HE Y L.Analysis of prophylactic application of antibiotics in 100 children in a perioperative period[J].Clin Pharmacoepidemiol,2007,16(5):304-306.
9YuY S,Du X X,Zhou Z H,et al.Firstisolation of blaIMP2 in an Enterobacter cloacae clinical isolate from China.A ntimicrob A ngents Chemother,2006,50(4):1610-1611.
10CLSI.Performance standards for a'ntimicrobial susceptibility testing;seventeenth informational supplement (M100S17),2007.
